Richard Macary
Fortune : 31 000 $ au 31/05/2026
Fortune : 31 000 $ au 31/05/2026
Richard Macary is Independent Director at iFabric Corp.
since 2022.
Mr. Macary is President & Director at Sinaptica Therapeutics, Inc. since 2022.
Formerly, Mr. Macary was Chief Strategy Officer at Delos Living LLC from 2017 to 2022.
Mr. Macary was Vice President-Business Development at Sarepta Therapeutics, Inc. from 2013 to 2016.
Mr. Macary was President at Delos Ventures.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IFABRIC CORP. 0,03 % | 16/05/2025 | 10 000 ( 0,03 % ) | 31 000 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| IFABRIC CORP. | Directeur/Membre du Conseil | 07/02/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
Delos Living LLC
Delos Living LLC Packaged SoftwareTechnology Services Develops rea estate software | Corporate Officer/Principal | 01/07/2022 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2016 |
Delos Ventures | President | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Delos Living LLC
Delos Living LLC Packaged SoftwareTechnology Services Develops rea estate software | Technology Services |
iFabric Corp.
iFabric Corp. Apparel/FootwearConsumer Non-Durables Manufactures and distributes ladies intimate apparel and accessories | Consumer Non-Durables |
Delos Ventures |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national